AbCellera announced the expansion of its executive team with the hiring of Andrew Booth as Chief Financial Officer and Tryn Stimart as General Counsel. In his role as CFO, Andrew Booth will assume responsibility for corporate finance and growth, and as General Counsel, Tryn Stimart will oversee all corporate legal matters and lead AbCellera's intellectual property strategy. Andrew Booth joins AbCellera from STEMCELL Technologies, where he held roles of Vice President of Instrumentation, Chief Financial Officer, and Chief Commercial Officer.

In connection with his appointment as CFO, Andrew will step down from AbCellera's Board of Directors, where he has served for the past four years. Tryn Stimart has over sixteen years' experience in biotech and pharma spanning mergers and acquisitions, financing, FDA regulatory procedures, licensing, litigation, IP strategy, and diligence. He comes to AbCellera from Gibbons P.C., where he was a partner based in its New York Office.